Immunohistochemical Coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral Squamous Cell Carcinoma

Overview

Journal Head Neck Pathol

Specialties Oncology
Pathology

Date 2021 Feb 5

PMID 33544383

Citations 2

Authors

Renu Rathee

Anju Devi

Anjali Narwal

Mala Kamboj

Sunita Singh

Affiliations

Soon will be listed here.

Abstract

MUC1 and MUC4 are two transmembranous proteins, which have been seen to express aberrantly in various human neoplasms and advocated as independent prognostic markers. Till now no extensive studies have been carried out on combined expression of MUC1 and MUC4 in oral leukoplakia and Oral squamous cell carcinoma. This study is an endeavour to evaluate Immunohistochemical coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral squamous cell carcinoma and furthr establish them as prognostic markers. Immunohistochemical analysis of MUC1 and MUC4 was done on 24 cases of Oral squamous cell carcinoma, 24 cases of leukoplakia and 12 normal oral mucosal tissues. Chi square test and one way ANOVA test were employed for statistical analysis. Normal oral mucosa and leukoplakia group showed higher frequency of negative immunoexpression compared to oral squamous cell carcinoma group. Furthur in Oral squamous cell carcinoma group, higher frequency of double positive coexpression in well and moderately differentiated oral squamous cell carcinoma and single positive coexpression in poorly differentiated oral squamous cell carcinoma was obtained. A definite rise of immunoexpression of MUC1 and MUC4 was observed from normal oral mucosa to leukoplakia to oral squamous cell carcinoma indicative of their contribution as diagnostic and prognostic markers.

Citing Articles

MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.

Abidullah M, Nahar P, Ahmed S, Kothari H, Vakeel S J Int Soc Prev Community Dent. 2023; 13(2):124-132.

PMID: 37223448 PMC: 10202254. DOI: 10.4103/jispcd.JISPCD_241_22.

Study on the mechanism of SALL4 down-regulation in promoting the invasion and migration of oral squamous cell carcinoma and influencing the survival and prognosis of patients.

Li J, Zhang B, Xu R, Wang B, Hao W, Zhang X Ann Transl Med. 2022; 10(14):792.

PMID: 35965794 PMC: 9372673. DOI: 10.21037/atm-22-2974.

References

Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M . MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. PLoS One. 2012; 7(11):e49251. PMC: 3496698. DOI: 10.1371/journal.pone.0049251. View

Mahfouz M, Rodrigo J, Takes R, Elsheikh M, Rinaldo A, Brakenhoff R . Current potential and limitations of molecular diagnostic methods in head and neck cancer. Eur Arch Otorhinolaryngol. 2009; 267(6):851-60. DOI: 10.1007/s00405-009-1177-3. View

Osako M, Yonezawa S, Siddiki B, Huang J, Ho J, Kim Y . Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer. 1993; 71(7):2191-9. DOI: 10.1002/1097-0142(19930401)71:7<2191::aid-cncr2820710705>3.0.co;2-x. View

Troeltzsch M, Knosel T, Eichinger C, Probst F, Troeltzsch M, Woodlock T . Clinicopathologic features of oral squamous cell carcinoma: do they vary in different age groups?. J Oral Maxillofac Surg. 2014; 72(7):1291-300. DOI: 10.1016/j.joms.2014.01.009. View

Yamashita K, Yonezawa S, Tanaka S, Shirahama H, Sakoda K, Imai K . Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer. 1993; 55(1):82-91. DOI: 10.1002/ijc.2910550116. View

Thakur A, Tupkari J, Joy T, Kende P, Siwach P, Ahire M . Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. J Oral Maxillofac Pathol. 2018; 22(2):210-215. PMC: 6097386. DOI: 10.4103/jomfp.JOMFP_188_17. View

Shibahara H, Tamada S, Higashi M, Goto M, Batra S, Hollingsworth M . MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology. 2004; 39(1):220-9. DOI: 10.1002/hep.20031. View

Tashiro Y, Yonezawa S, Kim Y, Sato E . Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. Hum Pathol. 1994; 25(4):364-72. DOI: 10.1016/0046-8177(94)90144-9. View

Tamada S, Shibahara H, Higashi M, Goto M, Batra S, Imai K . MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res. 2006; 12(14 Pt 1):4257-64. DOI: 10.1158/1078-0432.CCR-05-2814. View

10.

Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T . MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol. 2005; 58(8):845-52. PMC: 1770880. DOI: 10.1136/jcp.2004.023572. View

11.

Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, Wakimoto J . MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer. 2006; 55(2):195-203. DOI: 10.1016/j.lungcan.2006.10.013. View

12.

Kohli M, Shivam A, Ahuja P, Dutta J . Mucin-4: A novel marker for oral cancer. J Oral Maxillofac Pathol. 2019; 23(1):49-53. PMC: 6503802. DOI: 10.4103/jomfp.JOMFP_175_16. View

13.

Kamikawa Y, Kanmura Y, Hamada T, Yamada N, Macha M, Batra S . Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. Int J Clin Oncol. 2014; 20(2):298-307. DOI: 10.1007/s10147-014-0710-6. View

14.

Gupta N, Gupta R, Acharya A, Patthi B, Goud V, Reddy S . Changing Trends in oral cancer - a global scenario. Nepal J Epidemiol. 2017; 6(4):613-619. PMC: 5506386. DOI: 10.3126/nje.v6i4.17255. View

15.

Harish Kumar M, Sanjai K, Kumarswamy J, Keshavaiah R, Papaiah L, Divya S . Expression of MUC1 mucin in potentially malignant disorders, oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. J Oral Maxillofac Pathol. 2016; 20(2):214-8. PMC: 4989549. DOI: 10.4103/0973-029X.185916. View

16.

Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M . Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer. 2002; 94(6):1770-6. DOI: 10.1002/cncr.10398. View

17.

Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y . MUC4: a novel prognostic factor of oral squamous cell carcinoma. Int J Cancer. 2011; 130(8):1768-76. DOI: 10.1002/ijc.26187. View

18.

Nakamori S, Ota D, Cleary K, SHIROTANI K, Irimura T . MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology. 1994; 106(2):353-61. DOI: 10.1016/0016-5085(94)90592-4. View

19.

Zhang A, Chi X, Bo Z, Huang X, Zhang J . MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells. Biosci Rep. 2019; 39(9). PMC: 6747000. DOI: 10.1042/BSR20182193. View

20.

Warnakulasuriya S, Johnson N, van der Waal I . Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007; 36(10):575-80. DOI: 10.1111/j.1600-0714.2007.00582.x. View